首页> 外文会议>International conference on systems science, management science and system dynamics >Defects and Improvement: Analysis and Comparison of the Compulsory License on the Pharmaceutical Products in China and Developed Countries-from the view of TRIPS
【24h】

Defects and Improvement: Analysis and Comparison of the Compulsory License on the Pharmaceutical Products in China and Developed Countries-from the view of TRIPS

机译:缺陷与改进:中国与发达国家药品强制许可的比较分析-以TRIPS为视角

获取原文

摘要

The establishment of compulsory licensing on patented medicine limits the right of patent holder in order to resolve public health problem. The purpose of the system is to strive for the balance between the interests of patentees and public health. The author tries to reflect and reconsider the articles, effectiveness and relate legislation defects of "Patent Law of The People's Republic of China", "Implementing Regulations of The Patent Law of the People's Republic of China" and "Measures for Compulsory License on Patent Implementation concerning Public Health Problems". Furthermore, the author also point out the position China should take in the WTO negotiations on compulsory Licensing, on the basis of the comparativeness on the relate articles about the compulsory licensing on patented medicine in the TRIPS.
机译:专利药品强制许可的建立限制了专利持有人解决公共卫生问题的权利。该制度的目的是在专利权人利益与公共卫生之间寻求平衡。作者试图反映和重新考虑《中华人民共和国专利法》,《中华人民共和国专利法实施细则》,《专利实施强制许可办法》的条款,效力和相关立法缺陷。关于公共卫生问题”。此外,作者还指出,在与《与贸易有关的知识产权协议》中有关专利药品强制许可的相关条款的可比性的基础上,中国在世贸组织强制许可谈判中应采取的立场。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号